Literature DB >> 10832684

Amniotic membrane transplantation or conjunctival limbal autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries.

R T Pires1, A Chokshi, S C Tseng.   

Abstract

PURPOSE: To determine if human amniotic membrane transplantation or limbal stem cell transplantation is effective to restore the corneal surface with partial or total limbal stem cell deficiency, respectively, caused by 5-fluorouracil (5-FU) toxicity after glaucoma surgeries.
METHODS: Partial and total limbal stem cell deficiency was confirmed by impression cytology as the cause of reduced vision and corneal surface breakdown in a 69-year-old man and a 67-year-old man, respectively, who both had received a total of 105 mg 5-FU injections. Amniotic membrane transplantation or conjunctival limbal autograft was performed for corneal surface reconstruction, respectively.
RESULTS: For a period of 15 months of follow-up, the visual acuity improved, and their corneal surfaces remained avascular, smooth, and without recurrence of limbal stem cell deficiency.
CONCLUSION: Limbal stem cell deficiency can occur as a late complication for patients receiving 5-FU after glaucoma filtering surgeries. Partial limbal stem cell deficiency can be treated with amniotic membrane transplantation alone, whereas limbal transplantation must be considered as an alternative for total limbal stem cell deficiency to restore the corneal surface integrity and vision.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832684     DOI: 10.1097/00003226-200005000-00005

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

Review 1.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

2.  Stem cell-based therapy for treating limbal stem cells deficiency: A review of different strategies.

Authors:  Hong He; Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-06-26

3.  Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias.

Authors:  E M Espana; P Prabhasawat; M Grueterich; A Solomon; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

4.  Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency.

Authors:  Sophie X Deng; Vincent Borderie; Clara C Chan; Reza Dana; Francisco C Figueiredo; José A P Gomes; Graziella Pellegrini; Shigeto Shimmura; Friedrich E Kruse
Journal:  Cornea       Date:  2019-03       Impact factor: 2.651

5.  Limbal Stem Cell Deficiency After Glaucoma Surgery.

Authors:  Yuzhao Sun; Madeline Yung; Linying Huang; Chihong Tseng; Sophie X Deng
Journal:  Cornea       Date:  2020-05       Impact factor: 2.651

6.  Limbal stem cell deficiency arising from systemic chemotherapy with hydroxycarbamide.

Authors:  Xiaoyan Ding; Rachel J Bishop; Alexandra A Herzlich; Mrinali Patel; Chi-Chao Chan
Journal:  Cornea       Date:  2009-02       Impact factor: 2.651

7.  Ocular surface tumors.

Authors:  Ihab Saad Othman
Journal:  Oman J Ophthalmol       Date:  2009-01

8.  The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency.

Authors:  E Fok; S R Sandeman; A L Guildford; Y H Martin
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 9.  Presentation, diagnosis and management of limbal stem cell deficiency.

Authors:  Kunjal Sejpal; Pejman Bakhtiari; Sophie X Deng
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

10.  Adverse effects of the oral anticancer drug s-1: lacrimal passage impairment and specific features of corneal epitheliopathy.

Authors:  Ken-Ichi Sato; Shin-Ichi Nishimura
Journal:  Open Ophthalmol J       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.